These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35637350)

  • 1. Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1.
    Yang X; Wang X; Xu Z; Wu C; Zhou Y; Wang Y; Lin G; Li K; Wu M; Xia A; Liu J; Cheng L; Zou J; Yan W; Shao Z; Yang S
    Nat Chem Biol; 2022 Aug; 18(8):831-840. PubMed ID: 35637350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.
    Shao Z; Yan W; Chapman K; Ramesh K; Ferrell AJ; Yin J; Wang X; Xu Q; Rosenbaum DM
    Nat Chem Biol; 2019 Dec; 15(12):1199-1205. PubMed ID: 31659318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569.
    Aderibigbe AO; Pandey P; Doerksen RJ
    J Biomol Struct Dyn; 2022 Aug; 40(13):5729-5747. PubMed ID: 33480332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.
    Iliff HA; Lynch DL; Kotsikorou E; Reggio PH
    J Comput Chem; 2011 Jul; 32(10):2119-26. PubMed ID: 21523790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis Studies.
    Green HM; Fellner DMJ; Finlay DB; Furkert DP; Glass M
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1.
    Shen S; Wu C; Lin G; Yang X; Zhou Y; Zhao C; Miao Z; Tian X; Wang K; Yang Z; Liu Z; Guo N; Li Y; Xia A; Zhou P; Liu J; Yan W; Ke B; Yang S; Shao Z
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2321532121. PubMed ID: 38830102
    [No Abstract]   [Full Text] [Related]  

  • 8. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.
    Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH
    J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB
    Yang L; Zhu X; Finlay DB; Green H; Glass M; Duffull SB
    Br J Pharmacol; 2023 Oct; 180(20):2661-2676. PubMed ID: 37277184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.
    Obi P; Natesan S
    J Med Chem; 2022 Sep; 65(18):12240-12255. PubMed ID: 36066412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.
    Nguyen T; Li JX; Thomas BF; Wiley JL; Kenakin TP; Zhang Y
    Med Res Rev; 2017 May; 37(3):441-474. PubMed ID: 27879006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor.
    Saleh N; Hucke O; Kramer G; Schmidt E; Montel F; Lipinski R; Ferger B; Clark T; Hildebrand PW; Tautermann CS
    Angew Chem Int Ed Engl; 2018 Mar; 57(10):2580-2585. PubMed ID: 29314474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Binding Mechanisms for Allosteric Sodium Ion in Cannabinoid Receptors.
    Dutta S; Selvam B; Shukla D
    ACS Chem Neurosci; 2022 Feb; 13(3):379-389. PubMed ID: 35019279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Allosteric Modulation of CB
    Scott CE; Kendall DA
    Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
    Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
    Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.